Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Censa Pharmaceuticals

Censa Pharmaceuticals
2015 FOUNDED
PRIVATE STATUS
1-10 EMPLOYEES
M&A LATEST DEAL TYPE (Cancelled)
$65M LATEST DEAL AMOUNT
2 INVESTORS
Description

Developer of bio-medical therapeutics designed to treat (ultra) orphan CNS disorders. The company's bio-medical therapeutics treat orphan metabolic diseases with earlier stage programs targeting central nervous system diseases, disorders of neurotransmitter degradation and synthesis, enabling patients to recover debilitating diseases.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Drug Delivery
Pharmaceuticals
Primary Office
  • 65 William Street
  • Suite 200
  • Wellesley, MA 02481
  • United States

+1 (781) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Censa Pharmaceuticals’s full profile, request a free trial.

Censa Pharmaceuticals Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Merger/Acquisition 05-Jan-2018 $65M 0000 Cancelled Generating Revenue
2. Early Stage VC 21-Nov-2017 00.00 00.000 Completed Startup
1. Angel (individual) 19-Apr-2016 $1.51M $1.51M 000.00 Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Censa Pharmaceuticals Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned
Series A 000,000 00.000000 00 00 00 00 00 0.000
To view this company’s complete Cap Table, request access »

Censa Pharmaceuticals Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Arkin Holdings PE/Buyout Minority 000 0000 000000 0
InClin Other Minority 000 0000 000000 0

Censa Pharmaceuticals Executive Team (2)

Name Title Board
Seat
Contact
Info
Johnathan Reis MD President, Chief Executive Officer & Board Member
Christopher Schelling Founder and Board Member

Censa Pharmaceuticals Board Members (4)

Name Representing Role Since Contact
Info
Christopher Schelling Self Founder and Board Member 000 0000
Johnathan Reis MD Censa Pharmaceuticals President, Chief Executive Officer & Board Member 000 0000
Joseph Baron Censa Pharmaceuticals Board Member 000 0000
Pini Orbach Ph.D Arkin Holdings Board Member 000 0000